FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

BACKGROUND: The objective of this prospectively randomized phase II trial (Trial registration: EUCTR2004-004007-37-DE) was to compare the clinical response of primary breast cancer patients to neoadjuvant therapy with letrozole alone (LET) or letrozole and zoledronic acid (LET + ZOL). METHODS: Patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fasching, Peter A, Jud, Sebastian M, Hauschild, Maik, Kümmel, Sherko, Schütte, Martin, Warm, Matthias, Hanf, Volker, Grab, Dieter, Krocker, Jutta, Stickeler, Elmar, Kreienberg, Rolf, Müller, Thomas, Kühn, Thorsten, Wolf, Christopher, Kahlert, Steffen, Paepke, Stefan, Berghorn, Michael, Muth, Mathias, Baier, Monika, Wackwitz, Birgit, Schulz-Wendtland, Rüdiger, Beckmann, Matthias W, Lux, Michael P
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3937056/
https://ncbi.nlm.nih.gov/pubmed/24499441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-66
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados